rivastigmine has been researched along with Genetic Predisposition in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bayat, S; Ghahvechi Akbari, M; Rezaei Rad, F; Zamani, M | 1 |
| Broggio, E; Corbo, RM; Gambina, G; Scacchi, R | 1 |
| Charles, HC; Farlow, MR; He, Y; Lane, R; Tekin, S; Xu, J | 1 |
3 other study(ies) available for rivastigmine and Genetic Predisposition
| Article | Year |
|---|---|
Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer's Disease.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Case-Control Studies; Female; Genetic Association Studies; Genetic Predisposition to Disease; HLA Antigens; Humans; Iran; Male; Pharmacogenetics; Rivastigmine | 2021 |
Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Donepezil; Estrogen Receptor alpha; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polymorphism, Single Nucleotide; Rivastigmine; Sex Factors | 2014 |
Impact of APOE in mild cognitive impairment.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Atrophy; Cognition Disorders; Female; Genetic Predisposition to Disease; Genotype; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine | 2004 |